Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
carbapenem-hydrolyzing beta-lactamase
Overview
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| blaKPC-1 | Reslit | 1 | imipenem, meropenem +2 | Klebsiella pneumoniae +1 | - | 2001 | AF297554 | - |
| blaKPC-2 | Reslit |
| 4 |
| imipenem, ertapenem +3 |
| Klebsiella pneumoniae +3 |
| United States, Maryland, New York City |
| 2002, 2003, 2005 |
| AF055067|X77455|X91840|U58495|X04730 |
| - |
| blaKPC-3 | Reslit | 1 | carbapenems | Klebsiella pneumoniae | New York | 2004 | AF395881|AF482468 | - |
Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
The study identifies KPC-1, a novel class A carbapenem-hydrolyzing beta-lactamase, as the primary cause of carbapenem resistance in a Klebsiella pneumoniae strain. The gene was cloned and shown to confer resistance to multiple beta-lactam antibiotics.
Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.
The study identified several beta-lactamases, including bla DHA-1, bla ACT-1, bla FOX-5, bla CMY-2, and bla KPC-2, in Klebsiella pneumoniae isolates from 24 U.S. hospitals. These enzymes confer resistance to various beta-lactam antibiotics.
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.
The study identifies KPC-2, a plasmid-mediated class A carbapenemase, as the cause of imipenem resistance in a Salmonella enterica serotype Cubana isolate.
Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
The study identifies KPC-2, a class A carbapenem-hydrolyzing beta-lactamase, as the primary mechanism of carbapenem resistance in a clinical isolate of Klebsiella oxytoca. KPC-2 was shown to confer resistance to carbapenems, extended-spectrum cephalosporins, and aztreonam when cloned in E. coli.
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.
The study identifies a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, produced by carbapenem-resistant Klebsiella pneumoniae isolates. The enzyme was encoded on a 75-kb plasmid and conferred resistance to carbapenems, cephalosporins, and other beta-lactam antibiotics.
Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.
The study evaluates techniques for detecting carbapenem-resistant Klebsiella pneumoniae, highlighting the role of the bla KPC-2 gene in conferring resistance to carbapenems.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research